T1	Disorder 40 49	skin rash
N1 	Reference T1 UMLS:C0015230	skin rash
T2	Pharmacological_substance 77 89	methotrexate
N1000 	Reference T2 MeSH:D008727	methotrexate
T3	Disorder 125 180	metastatic squamous cell carcinoma of the head and neck
T4	Disorder 198 207	skin rash
N2 	Reference T4 UMLS:C0015230	skin rash
T6	Pharmacological_substance 296 308	methotrexate
N1001 	Reference T6 MeSH:D008727	methotrexate
T7	Pharmacological_substance 310 313	MTX
N1002 	Reference T7 MeSH:D008727	MTX
T8	Disorder 316 325	Skin rash
N3 	Reference T8 UMLS:C0015230	Skin rash
T9	Disorder 423 432	skin rash
N4 	Reference T9 UMLS:C0015230	skin rash
T10	Disorder 567 579	pancytopenia
N5 	Reference T10 UMLS:C0030312	pancytopenia
T11	Pharmacological_substance 694 731	granulocyte colony stimulating factor
N1003 	Reference T11 MeSH:D016179	granulocyte colony stimulating factor
T13	Disorder 759 768	mucositis
N6 	Reference T13 UMLS:C0333355	mucositis
T14	Disorder 772 780	diarrhea
N7 	Reference T14 UMLS:C0011991	diarrhea
T15	Disorder 789 810	dermatologic toxicity
N8 	Reference T15 UMLS:C0600688	dermatologic toxicity
T16	Disorder 883 899	hypersensitivity
N9 	Reference T16 UMLS:C0020517	hypersensitivity
T17	Pharmacological_substance 912 915	MTX
N1004 	Reference T17 MeSH:D008727	MTX
T18	Disorder 961 970	skin rash
N10 	Reference T18 UMLS:C0015230	skin rash
T19	Pharmacological_substance 998 1001	MTX
N1005 	Reference T19 MeSH:D008727	MTX
T5	Subject 94 109	64 year old man
T12	Disorder 625 632	aplasia
N11 	Reference T12 UMLS:C0243065	aplasia
T20	Disorder 1052 1071	bone marrow aplasia
N12 	Reference T20 UMLS:C1368107	bone marrow aplasia
N13 	Reference T20 UMLS:C0002874	bone marrow aplasia
T21	Disorder 9 28	Bone marrow aplasia
N14 	Reference T21 UMLS:C1368107	Bone marrow aplasia
N15 	Reference T21 UMLS:C0002874	Bone marrow aplasia
T23	Disorder 212 231	bone marrow aplasia
N16 	Reference T23 UMLS:C1368107	bone marrow aplasia
N17 	Reference T23 UMLS:C0002874	bone marrow aplasia
T26	Disorder 864 872;900 908	allergic reaction
N18 	Reference T26 UMLS:C1527304	allergic reaction
N19 	Reference T26 UMLS:C0020517	allergic reaction
T32	Coreferring_mention 842 850	the drug
T34	Negation_cue 748 755	absence
T35	Coreferring_mention 919 931	this patient
T41	Disorder 446 493	superficial perivascular lymphocytic infiltrate
N20 	Reference T41 UMLS:C0332448	superficial perivascular lymphocytic infiltrate
T42	Speculation_cue 851 859	suggests
